#Pharmaceutical Innovation

Articles (10)

• 🇺🇸 Vanda initiates trial of NEREUS for GLP-1 therapy side effects — 08/04/2026 [USA] Related: #Clinical Trials, #Market Strategy
• 🇺🇸 Lilly’s Taltz plus Zepbound shows efficacy in psoriatic arthritis trial — 28/03/2026 [USA] Related: #Clinical Trials, #Psoriatic Arthritis Treatment, #Combination Therapy
• 🇺🇸 Syndax Q4 2025 slides: dual product launch drives revenue beat — 26/03/2026 [USA] Related: #Market Performance, #Product Strategy
• 🇺🇸 EyePoint at TD Cowen Conference: DURAVYU’s Market Potential — 04/03/2026 [USA] Related: #Market Challenges, #Strategic Development
• 🇺🇸 11/03/2024: Election Truth; Unintended Consequences; The Land of Novo — 04/03/2026 [USA]

  First, how Georgia election officials fight voting misinformation. Then, a look at the consequences of Texas' strict abortion laws. And, meet the Novo Nordisk scientist behind Ozempic, Wegovy.

  Related: #Election Integrity, #Healthcare Policy
• 🇺🇸 Compass Pathways at TD Cowen Conference: Promising Data for Depression Drug — 03/03/2026 [USA] Related: #Mental Health Treatment, #Clinical Trials, #Regulatory Affairs
• 🇺🇸 VistaGen at TD Cowen Conference: Pherine Platform in Focus — 03/03/2026 [USA] Related: #Biotechnology, #Healthcare Investment
• 🇺🇸 Argenx SE FY25 swings to profit as Vyvgart sales double — 26/02/2026 [USA] Related: #Financial Performance, #Market Expansion
• 🇺🇸 Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment — 20/02/2026 [USA]

  Shares of Japan's Sumitomo Pharma fell over 12% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinson's disease.

  Related: #Stock Market Volatility, #Regenerative Medicine
• 🇺🇸 Merck and Mayo Clinic partner on AI-driven drug discovery — 18/02/2026 [USA] Related: #Artificial Intelligence, #Healthcare Partnerships